ORIGINAL ARTICLE. Upper Aerodigestive Tract Cancer in Patients With Chronic Lymphocytic Leukemia
|
|
- Russell Baker
- 5 years ago
- Views:
Transcription
1 ORIGINAL ARTICLE Upper Aerodigestive Tract Cancer in Patients With Chronic Lymphocytic Leukemia Incidence, Stage, and Outcome Nitin A. Pagedar, MD; Thorvardur R. Halfdanarson, MD; Lucy H. Karnell, PhD; Henry T. Hoffman, MD; Gerry F. Funk, MD Objective: To compare incidence, stage, and survival of upper aerodigestive tract (UADT) cancers in patients with and without chronic lymphocytic leukemia (). Design: Inception cohort. Setting: National database. Patients: Individuals with and UADT cancers included in the Surveillance, Epidemiology, and End Results (SEER) database. Main Outcome Measures: Incidence was compared by computing standardized incidence ratio (SIR), the ratio of observed UADT cancers in patients with, and the number of UADT cancers expected based on the characteristics of patients with and population incidence of UADT cancers. The association between and UADT cancer stage was measured using odds ratio (OR) calculations. Survival of patients with UADT cancer with and without was compared. Results: For the SIR calculation, patients with contributed a mean 6.36 years of follow-up each, for a total of person-years of follow-up. The SIR was 1.18 (95% CI, ) for UADT cancers; 1.52 (95% CI, ) for laryngeal cancer; and 1.92 (95% CI, ) for cancers of the nasal cavity and paranasal sinuses. In the stage and survival analyses, 253 patients with followed by a UADT cancer were compared with patients with 1 UADT cancer only. Cancers of the UADT in patients with were more likely localized (OR, 0.50; 95% CI, ). Relative survival was worse in patients with. In multivariate analysis, was independently associated with poorer observed survival (hazard ratio, 1.45; 95% CI, ). Conclusions: Larynx and nasal cavity cancers were more common in patients with. Overall incidence of UADT cancers was not significantly elevated. Cancers of the UADT in patients with were more likely to be localized at diagnosis than those in patients without. Finally, was associated with poorer survival outcomes. Arch Otolaryngol Head Neck Surg. 2012;138(12): Author Affiliations: Departments of Otolaryngology Head and Neck Surgery (Drs Pagedar, Karnell, Hoffman, and Funk) and Medicine (Dr Halfdanarson), University of Iowa Carver College of Medicine, Iowa City. CHRONIC LYMPHOCYTIC LEUkemia () is the most common leukemia in adults in the United States, with an age-adjusted annual incidence of 4.7 per men and 2.5 per women. The incidence increases with age. 1 Immunosuppression is commonly considered a hallmark of. Between 25% and 50% of patients with ultimately die of infection, most frequently involving the respiratory or urinary tracts. 2 Small lymphocytic lymphoma is an indolent B-cell malignant condition, which is immunophenotypically identical to but lacks the circulating lymphocytosis seen in. The current World Health Organization classification considers small lymphocytic lymphoma and as a single entity. 3,4 Conditions causing immunosuppression are frequently associated with alterations in the behavior of neoplasms. A recent study described changes in cancer incidence in patients who had undergone a solid-organ transplant, 5 and human immunodeficiency virus related cancers have been well described. Chronic lymphocytic leukemia has been studied in this context by Travis et al, 6 Hisada et al, 7 and Morton et al. 8 Ishibe and Curtis, 9 using the National Cancer Institute s Surveillance, Epidemiology, and End Results (SEER) database, reported a statistically significant 19% increase in the risk of subsequent primary cancers in patients with, with the lip, larynx, and nasal cavity among the primary sites demonstrating increased risk. Staging and outcomes were not reported in that study. Author Affil Departments Otolaryngolo Surgery (Drs Hoffman, an Medicine (D University o College of M 1171
2 Table 1. Effect of on Incidence of Cancer at UADT Subsites a Site SIR (95% CI) All UADT sites 1.18 ( ) Oral cavity 7 (0-1.39) All pharynx 0.75 (0.52-5) Oropharynx 9 (3-6) Hypopharynx 5 (8-1.29) Nasopharynx 1.47 ( ) Larynx 1.52 ( ) b Nasal cavity/paranasal sinuses 1.92 (5-3.23) b Abbreviations:, chronic lymphocytic leukemia; SIR, standardized incidence ratio; UADT, upper aerodigestive tract. a Standardized incidence ratios comparing the incidence of UADT cancers in patients with with that in the general population. b Sites for which the SIR is significantly different from 1. The purpose of this study was to describe the effect of on the incidence, stage at diagnosis, and natural history of subsequent cancers of the upper aerodigestive tract (UADT). This study represents the addition of 8 years of data to the work published by Ishibe and Curtis. 9 In addition, we sought to describe the stage at presentation and outcomes of UADT cancers occurring in patients with a prior diagnosis of. METHODS This study used deidentified data in a public-use data set and therefore did not require institutional review board approval. Data were obtained from SEER using SEER*Stat software. 10 This database includes comprehensive cancer incidence data in 9 geographic locations (Atlanta, Connecticut, Detroit, Hawaii, Iowa, New Mexico, San Francisco/Oakland, Seattle/Puget Sound, and Utah) from 1973 through 2008, in 4 more locations (Los Angeles, San Jose/Monterey, Alaska Natives, and rural Georgia) from 1992 through 2008, and in an additional 4 locations (Kentucky, New Jersey, Louisiana, and greater California) from 2000 through The 9-registry database covers approximately 10% of the US population, and the full 17-registry database covers approximately 26% of the US population. We defined and small lymphocytic lymphoma using the International Classification of Diseases for Oncology, Third Edition (ICD-O-3) histology codes 9670 and 9823, respectively. Upper aerodigestive tract cancers were defined using ICD- O-3 primary site codes C0-C14.8 and C3-C32.9. All histologic types at UADT sites were included. To compare incidence, SEER*Stat software was used to compute standardized incidence ratios (SIRs) for UADT sites from population incidence rates adjusted for age, race, and sex. This inquiry was limited by SEER*Stat to the 9-registry database. The SIR compares the number of observed cases to the number of cases expected based on the population characteristics of patients with, the incidence of UADT cancer in specified populations, and the number of years of follow-up per patient with. The standard SEER rate files were modified to classify the tongue base as an oropharynx site, in contrast to its ICD-O-3 topographic classification in the oral cavity. To minimize the possibility of including UADT cancers that existed at the time the was diagnosed, UADT cancers were included only if diagnosed 2 or more months after the. The remainder of the analysis was performed on data from the full 17-registry SEER database over the years 1973 through 2008, using SAS 9.2 software (SAS Institute Inc). Stage at presentation, treatment, and survival outcomes were compared between 2 cohorts: patients who had and a subsequent UADT cancer and those who had a single UADT cancer and no other cancers. Odds ratios (ORs) for the association between and SEER stage (local/regional/distant) were calculated, with Mantel- Haenszel adjustment for primary site. The 2 test was used to evaluate statistical significance. Odds ratios were calculated using patients with known stage. Multivariate Cox proportional hazards analysis was used to investigate the effect of on observed survival, correcting for age, stage, primary site, and year of diagnosis. We sought to correct for the effect of deaths unrelated to cancer by comparing relative survival based on stage. The reliability of cause-of-death data in registries, including SEER, is questionable, especially for UADT cancers. 11 We therefore used relative survival, rather than cause-specific survival, to evaluate the survival effect of in patients with UADT cancer. Relative survival compares survival observed in the cohort of interest with that expected in an otherwise identical cohort without cancer. 12 Expected survival is computed from US population data, accounting for the age, year, sex, and race composition of the cohort of interest. While calculation of cause-specific survival depends on the accuracy of individual death certificates, the SEER*Stat calculation of relative survival relies on the assumption that the population mortality of the cancer of interest is small, so that the survival outcomes of the entire US population are used to approximate those of a cohort without cancer. SEER*Prep software ( was used to create an analytic data set from the 2 cohorts (one with UADT cancer alone and the other with both UADT cancer and ). For each stage, SEER*Stat was then used to compute relative survival. Statistical comparison of relative survival estimates was performed using a semiparametric model with CANSURV (Statistical Research and Applications Branch, National Cancer Institute) as described by Gamel et al. 13 RESULTS During the study period, patients were diagnosed as having, with person-years of follow-up, representing a mean of 6.36 follow-up years per patient. The resulting SIR data are given in Table 1. The SIR for cancers of all UADT sites was 1.18 (95% CI, ). In other words, the incidence of UADT cancer was 18% greater in patients with. The SIR for laryngeal cancer was 1.52 (95% CI, ), and for nasal cavity and paranasal sinus sites, 1.92 (95% CI, ). To account for potential changes in incidence of oropharynx cancer related to human papillomavirus, separate SIRs were calculated for the periods 1973 through 1995 and 1996 through The SIR for oropharynx cancer for the period 1973 through 1995 was 0.91 (95% CI, ), and in the later period, 4 (95% CI, ). The latter was statistically significant, although with 13.7 oropharynx cancers expected, the sample size was small. The full 17-registry SEER database contained 253 patients with and a subsequent head and neck cancer. There were patients with 1 head and neck cancer and no other cancers. Comparisons of the 2 cohorts are given in Table 2. Patients with were more 1172
3 Table 2. Characteristics of Patients With UADT Cancer With and Without a Characteristic UADT and (n = 253) UADT Only (n = ) P Value Male, % Age, mean, y Primary site distribution, No. (%) Oral cavity 88 (34.8) (3) Larynx 97 (38.3) (26.8) Oropharynx 38 (15.0) (25.5) Hypopharynx 5 (2.0) 7711 (5.8) Nasopharynx 7 (2.8) 7731 (5.8).001 Nasal 18 (7.1) 6918 (5.2) cavity/paranasal sinuses Stage at presentation, No. (%) Localized 115 (58.4) (36.2) Regional 66 (33.5) (51.2).001 Distant 16 (6.3) (12.6) Abbreviations:, chronic lymphocytic leukemia; UADT, upper aerodigestive tract. a Comparison of findings of UADT cancers in patients with and without. Age refers to age at the time of UADT cancer diagnosis. The percentages shown with stage groupings represent the proportion of cases with known stage. In the UADT and cohort, there were 56 cases of unknown stage (22%), and in the UADT only cohort, there were cases of unknown stage (15%). likely to be male and were on average a decade older at the time of diagnosis of UADT cancer. As given in Table 2, the overall distribution of primary sites within the UADT differed between the groups, with the most clinically significant differences being the more frequent laryngeal cancers and less frequent oropharynx cancers in the group. Importantly, these data were in agreement with the SIR data reported in Table 1, which were derived from the 9-registry database. Also given in Table 2 is the distribution of UADT cancer stage at presentation. Head and neck cancers were less likely to demonstrate regional or distant spread in patients with, with an OR of 0 (95% CI, ) (P.001). Primary site may well be a confounder in the association between and stage at presentation, so the Mantel-Haenszel OR was calculated. After adjusting for primary site, the OR was 0.50 (95% CI, ) (P.001) (Breslow-Day test of homogeneity, P =.58, indicating validity of the adjusted OR). We used follow-up data to compute actuarial observed survival estimates comparing patients with and those without. The estimates are shown in Figure 1. The survival estimates for the and the non- group were different (log-rank, P.001). A multivariate Cox proportional hazard model was developed to evaluate the effect of on observed survival. The model also included age, stage, primary site, and year of diagnosis. The results are given in Table 3. The hazard ratio for was 1.45 (95% CI, ) (P.001). The proportional hazard assumption was verified (data not shown) Months Since UADT Cancer Diagnosis Figure 1. Actuarial estimate of observed survival, comparing patients with both upper aerodigestive tract (UADT) cancer and chronic lymphocytic leukemia () and those with UADT cancer only. Table 3. Cox Proportional Hazard Analysis of Observed Survival a Variable HR (95% CI) P Value 1.45 ( ).001 Age 4 (36-37).001 Regional stage 2.07 ( ).001 Distant stage 3.94 ( ).001 Oropharynx 1.10 (8-1.12).001 Nasopharynx 0.99 (0.96-3).74 Hypopharynx 1.65 ( ).001 Nasal cavity/paranasal sinuses 4 (0-9).03 Larynx 1 (0.99-3).16 Abbreviations:, chronic lymphocytic leukemia; HR, hazard ratio. a Results of multivariate Cox proportional hazard analysis of observed survival, including all patients. The HRs for regional and distant stage are shown in comparison with localized stage. The values for the upper aerodigestive tract primary sites are shown in comparison with oral cavity site. We generated separate relative survival comparisons data for local, regional, and distant cancers. For each stage, the difference in relative survival between the and non- groups was significant (P.001). The relative survival estimates for local and regional UADT cancers are shown in Figure 2. COMMENT These data represent an update of earlier studies with additional data on stage and survival. The inclusion of data from 2000 through 2008 adds significantly to the report of Ishibe and Curtis. 9 Specifically, the latter study included more than patients followed for approximately person-years. The present report more than doubles the sample size. Two other national registrybased studies have reported standardized incidence ratios for second primary UADT cancers in patients with a history of. Schöllkopf et al, 14 studying the Danish cancer registry, did not identify altered incidence of UADT cancers. Royle and colleagues 15 analyzed second cancers in patients with using an Australian cancer registry and reported an increase in the risk of cancers of 1173
4 A B the oral cavity, pharynx, and larynx. The present study represents includes substantially more patients and longer follow-up. It is not clear why the 3 registries would produce different findings. The reasons for the effect of on UADT cancer incidence are not known. Immunosuppression associated with, either intrinsic to the itself or related to the treatments used, is a primary consideration. The UADT sites, which are more susceptible, are not ones typically associated with virally mediated carcinogenesis. In fact, given the incidence findings in the later-period ( ) cohort, there may be a protective effect in the oropharynx, where human papillomavirus is known to be a causative factor. Hisada et al 7 proposed a role for shared risk factors, such as tobacco use, since cancers of the lung occurred at a higher-thanexpected rate. However, tobacco use is also a strong risk factor for oral cancer, which was not more likely in patients with. Our study identified differences in stage at presentation, with UADT cancers more likely to be localized in patients with. A possible explanation for this is a surveillance bias. Typically, patients with maintain regular follow-up with a medical oncologist 2 to 4 times per year and therefore might be more likely to receive Months Since UADT Cancer Diagnosis Figure 2. Actuarial estimate of relative survival for patients with localized (A) and regionalized (B) upper aerodigestive tract (UADT) cancer. Patients with chronic lymphocytic leukemia () have poorer survival. referral for evaluation of UADT-related symptoms that might permit earlier diagnosis. The SEER data set did not permit us to compare how UADT cancers were treated in patients with and in those without. The SEER database provides reliably complete information about surgical treatment and radiotherapy. However, matching chemotherapy information is not available. Without accounting for the use of chemotherapy, it is not possible to usefully compare treatment regimens for UADT cancers or assess the effect of therapy directed at. The relationship between and squamous and basal cell carcinomas of the skin is of interest to head and neck oncologists. That relationship is not described in this study because those common cutaneous malignant conditions are not reported to SEER. A significant issue facing this group of patients is perioperative morbidity and mortality. Our study does not address this topic. Immunosuppression is frequently considered a powerful risk factor for postoperative woundhealing complications. Unfortunately, the SEER database does not contain variables that would permit assessment of this relevant question. Additional studies involving review of patient medical records would be required to address this important issue. In conclusion, the experience of UADT carcinoma is different in patients with a history of. Incidence rates are higher than expected in the larynx and in the nasal cavity and paranasal sinuses. Staging data demonstrate a likely surveillance effect, with patients with presenting at earlier stage. Chronic lymphocytic leukemia is an independent risk factor for mortality in patients with UADT cancer. Submitted for Publication: July 12, 2012; final revision received August 21, 2012; accepted September 7, Correspondence: Nitin A. Pagedar, MD, Department of Otolaryngology Head and Neck Surgery, University of Iowa, 200 Hawkins Dr, Iowa City, IA Author Contributions: Dr Pagedar had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Pagedar, Halfdanarson, and Hoffman. Acquisition of data: Pagedar and Karnell. Analysis and interpretation of data: Pagedar, Halfdanarson, Karnell, Hoffman, and Funk. Drafting of the manuscript: Pagedar, Halfdanarson, Hoffman, and Funk. Critical revision of the manuscript for important intellectual content: Halfdanarson, Karnell, Hoffman, and Funk. Statistical analysis: Pagedar, Halfdanarson, and Karnell. Study supervision: Hoffman and Funk. Conflict of Interest Disclosures: None reported. Previous Presentation: This study was presented as a poster at the Eighth International Head and Neck Cancer Conference; July 22, 2012; Toronto, Ontario, Canada. REFERENCES 1. Grever MR, Andritsos LA, Lozanski G. Chronic lymphoid leukemias. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG, eds. Abeloff s Clinical Oncology. 4th ed. Philadelphia, PA: Churchill Livingstone; 2008:
5 2. Hamblin AD, Hamblin TJ. The immunodeficiency of chronic lymphocytic leukaemia. Br Med Bull. 2008;87: Kurtin PJ. Indolent lymphomas of mature B lymphocytes. Hematol Oncol Clin North Am. 2009;23(4): Muller-Hermelink HK, et al. Chronic lymphocytic leukemia/small lymphocytic lymphoma. In: Swerdlow S, Campo E, Harris NL, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008: Engels EA, Pfeiffer RM, Fraumeni JF Jr, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011;306(17): Travis LB, Curtis RE, Hankey BF, Fraumeni JF Jr. Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst. 1992;84(18): Hisada M, Biggar RJ, Greene MH, Fraumeni JF Jr, Travis LB. Solid tumors after chronic lymphocytic leukemia. Blood. 2001;98(6): Morton LM, Curtis RE, Linet MS, et al. Second malignancy risks after non- Hodgkin s lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype. J Clin Oncol. 2010;28(33): Ishibe N, Curtis RE, et al. New malignancies following leukemia. In: Curtis RE, Freedman DM, Ron E, edsnew Malignancies Among Cancer Survivors: SEER Cancer Registries, Bethesda, MD: National Cancer Institute; 2006: NIH publication Surveillance, Epidemiology, and End Results (SEER) Program (http: // SEER*Stat Database: Incidence SEER 9 Regs Research Data, Nov 2010 Sub ( ) Katrina/Rita Population Adjustment Linked To County Attributes Total US, Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control & Population Sciences, Surveillance Research Program, Cancer Statistics Branch; April 2011 (updated October 28, 2011), based on the November 2010 submission. 11. German RR, Fink AK, Heron M, et al; Accuracy of Cancer Mortality Study Group. The accuracy of cancer mortality statistics based on death certificates in the United States. Cancer Epidemiol. 2011;35(2): Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr. 1961;6: Gamel JW, Weller EA, Wesley MN, Feuer EJ. Parametric cure models of relative and cause-specific survival for grouped survival times. Comput Methods Programs Biomed. 2000;61(2): Schöllkopf C, Rosendahl D, Rostgaard K, Pipper C, Hjalgrim H. Risk of second cancer after chronic lymphocytic leukemia. Int J Cancer. 2007;121(1): Royle JA, Baade PD, Joske D, Girschik J, Fritschi L. Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a populationbased study. Br J Cancer. 2011;105(7):
Oncologist. The. Outcomes Research. Changes in Survival in Head and Neck Cancers in the Late 20th and Early 21st Century: A Period Analysis
The Oncologist Outcomes Research Changes in Survival in Head and Neck Cancers in the Late 20th and Early 21st Century: A Period Analysis DIANNE PULTE, a,b HERMANN BRENNER a a Division of Clinical Epidemiology
More informationKey Words. Cancer statistics Incidence Lifetime risk Multiple primaries Survival SEER
The Oncologist Epidemiology and Population Studies: SEER Series Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) Program MATTHEW
More informationThe projection of short- and long-term survival for. Conditional Survival Among Patients With Carcinoma of the Lung*
Conditional Survival Among Patients With Carcinoma of the Lung* Ray M. Merrill, PhD, MPH; Donald Earl Henson, MD; and Michael Barnes, PhD Objective: One- and 5-year probabilities of survival or death change
More informationCancer in Estonia 2014
Cancer in Estonia 2014 Estonian Cancer Registry (ECR) is a population-based registry that collects data on all cancer cases in Estonia. More information about ECR is available at the webpage of National
More informationErrata Corrected 17 January, 2017
Errata Corrected 17 January, 2017 Previously, colorectal cancer was erroneously omitted as the second leading cancer, by frequency, among Alaska Native Women in the Interior Tribal Health Region from 1984
More informationSurvival in sinonasal and middle ear malignancies: a population-based study using the SEER database
Gore BMC Ear, Nose and Throat Disorders (2018) 18:13 https://doi.org/10.1186/s12901-018-0061-4 RESEARCH ARTICLE Open Access Survival in sinonasal and middle ear malignancies: a population-based study using
More informationChapter 13 Cancer of the Female Breast
Lynn A. Gloeckler Ries and Milton P. Eisner INTRODUCTION This study presents survival analyses for female breast cancer based on 302,763 adult cases from the Surveillance, Epidemiology, and End Results
More informationDescriptive Epidemiology: U.S. Patterns
Descriptive Epidemiology: U.S. Patterns Linda Morris Brown, Gloria Gridley, and Susan S. Devesa Abbreviations US HN SEER HPV ICD-O-3 API AI/AN United States head and neck Surveillance, Epidemiology, and
More informationCancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S.
Cancer Causes Control (2008) 19:227 256 DOI 10.1007/s10552-007-9088-3 ORIGINAL PAPER Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S. Barry A. Miller
More informationIncidence of HPV-Associated Head and Neck Cancers by Sub-site Among Diverse Racial/Ethnic Populations in the United States
Incidence of HPV-Associated Head and Neck Cancers by Sub-site Among Diverse Racial/Ethnic Populations in the United States Louisiana Tumor Registry LSUHSC School of Public Health Lauren Cole, MPH Linda
More informationExamining Subsequent Occurrence and Outcomes of Estrogen-related Cancers (Breast and Thyroid) in Missouri Women
Examining Subsequent Occurrence and Outcomes of Estrogen-related Cancers (Breast and Thyroid) in Missouri Women Iris Zachary, PhD, MSHI, CTR; Jeannette Jackson-Thompson, MSPH, PhD; Chester Schmaltz, PhD
More informationCCSS Concept Proposal Working Group: Biostatistics and Epidemiology
Draft date: June 26, 2010 CCSS Concept Proposal Working Group: Biostatistics and Epidemiology Title: Conditional Survival in Pediatric Malignancies: A Comparison of CCSS and SEER Data Proposed Investigators:
More informationTHE SURVIVORSHIP EXPERIENCE IN PANCREATIC CANCER
THE SURVIVORSHIP EXPERIENCE IN PANCREATIC CANCER Casey A. Boyd, Jaime Benarroch, Kristin M. Sheffield, Yimei Han, Catherine D. Cooksley, Taylor S. Riall Department of Surgery The University of Texas Medical
More informationOral Cavity and Oropharynx Cancer Trends
Oral Cavity and Oropharynx Cancer Trends Darien Weatherspoon, DDS, MPH Diplomate, American Board of Dental Public Health Program Officer, National Institute of Dental and Craniofacial Research National
More informationORIGINAL ARTICLE. Five-Year Survival Rates and Time Trends of Laryngeal Cancer in the US Population
ORIGINAL ARTICLE Five-Year Survival Rates and Time Trends of Laryngeal Cancer in the US Population Maura Cosetti, MD; Guo-Pei Yu, MD; Stimson P. Schantz, MD Objectives: To provide comprehensive temporal
More informationORIGINAL ARTICLE. US Mortality Rates for Oral Cavity and Pharyngeal Cancer by Educational Attainment
ORIGINAL ARTICLE US Mortality Rates for Oral Cavity and Pharyngeal Cancer by Educational Attainment Amy Y. Chen, MD, MPH; Carol DeSantis, MPH; Ahmedin Jemal, PhD Objective: To describe trends in mortality
More informationTrends in Cancer Survival in Scotland
Scottish Cancer Intelligence Unit Trends in Cancer Survival in Scotland - Trends in survival are presented for the half million adult cancer patients diagnosed in Scotland between and. The Results show,
More informationHead and Neck Cancer in FA: Risks, Prevention, Screening, & Treatment Options David I. Kutler, M.D., F.A.C.S.
Head and Neck Cancer in FA: Risks, Prevention, Screening, & Treatment Options David I. Kutler, M.D., F.A.C.S. Associate Professor Division of Head and Neck Surgery Department of Otolaryngology-Head and
More informationBasaloid Squamous Cell Carcinoma of the Oral Cavity: An Analysis of 92 Cases
The Laryngoscope VC 2013 The American Laryngological, Rhinological and Otological Society, Inc. Basaloid Squamous Cell Carcinoma of the Oral Cavity: An Analysis of 92 Cases Valerie A. Fritsch, MD; Daniel
More informationAccuracy of the SEER HPV status site specific factor 10 (SSF-10) variable for head and neck cancer (HNC) cases in Iowa:
Accuracy of the SEER HPV status site specific factor 10 (SSF-10) variable for head and neck cancer (HNC) cases in Iowa: 2010-2014 Amanda Kahl, MPH Mary Charlton, PhD, Nitin Pagedar, MD, MPH, Steven Sperry,
More informationLouisiana Cancer Facts & Figures, Oral Cavity and Pharynx Cancer, 2016
Louisiana Cancer Facts & Figures, Oral Cavity and Pharynx Cancer, 2016 Louisiana Tumor Registry September, 2016 Oral Cavity and Pharynx Cancer* Oral cavity and pharynx cancer was the 12 th most commonly
More informationKey Words. SEER Cancer Survival Incidence Mortality Prevalence
The Oncologist Cancer Survival and Incidence from the Surveillance, Epidemiology, and End Results (SEER) Program LYNN A. GLOECKLER RIES, MARSHA E. REICHMAN, DENISE RIEDEL LEWIS, BENJAMIN F. HANKEY, BRENDA
More informationHypopharyngeal Cancer Incidence, Treatment, and Survival: Temporal Trends in the United States
The Laryngoscope VC 2014 The American Laryngological, Rhinological and Otological Society, Inc. Hypopharyngeal Cancer Incidence, Treatment, and Survival: Temporal Trends in the United States Phoebe Kuo,
More informationCancer survival in Chennai (Madras), India,
Cancer survival in Chennai (Madras), India, 199 1999 Swaminathan R, Rama R, Nalini S and Shanta V Abstract The Madras metropolitan tumour registry was established in 1981, and registration of incident
More informationOverview of Gynecologic Cancers in New Jersey
Overview of Gynecologic Cancers in New Jersey New Jersey State Cancer Registry Antoinette M. Stroup, PhD presented at: Gynecologic Cancer Symposium: Striving for a Healthier Tomorrow, Today November 19,
More informationA Methodological Issue in the Analysis of Second-Primary Cancer Incidence in Long-Term Survivors of Childhood Cancers
American Journal of Epidemiology Copyright 2003 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 158, No. 11 Printed in U.S.A. DOI: 10.1093/aje/kwg278 PRACTICE OF EPIDEMIOLOGY
More informationConstruction of a North American Cancer Survival Index to Measure Progress of Cancer Control Efforts
Construction of a North American Cancer Survival Index to Measure Progress of Cancer Control Efforts Chris Johnson, Cancer Data Registry of Idaho NAACCR 2016 Annual Conference June 14, 2016 Concurrent
More informationORIGINAL ARTICLE. Incidence and Survival Rates for Young Blacks With Nasopharyngeal Carcinoma
ORIGINAL ARTICLE Incidence and Survival Rates for Young Blacks With Nasopharyngeal Carcinoma in the United States Luke M. Richey, BA; Andrew F. Olshan, PhD; Jonathan George, BA; Carol G. Shores, MD, PhD;
More informationCancer survival in Hong Kong SAR, China,
Chapter 5 Cancer survival in Hong Kong SAR, China, 1996 2001 Law SC and Mang OW Abstract The Hong Kong cancer registry was established in 1963, and cancer registration is done by passive and active methods.
More informationHEALTH EFFECTS OF PRESERVED WOOD: RELATIONSHIP BETWEEN CCA- TREATED WOOD AND INCIDENCE OF CANCER IN THE UNITED STATES. Daniel C.
HEALTH EFFECTS OF PRESERVED WOOD: RELATIONSHIP BETWEEN CCA- TREATED WOOD AND INCIDENCE OF CANCER IN THE UNITED STATES Daniel C. West, MD Associate Professor of Pediatrics University of California, Davis
More informationOVERALL SURVIVAL IN PATIENTS WITH STAGE IV NON-SMALL CELL LUNG CANCER
OVERALL SURVIVAL IN PATIENTS WITH STAGE IV NON-SMALL CELL LUNG CANCER Author Chayawut Punsriwong Chayakamon Niyasom Pariphat Chompoonutprapa Sarut Pravitkulawath 5 th year medical student Naresuan University
More informationBREAST CANCER IN TARRANT COUNTY: Screening, Incidence, Mortality, and Stage at Diagnosis
NIMHD* CENTER OF EXCELLENCE: COMMUNITY OUTREACH CORE* BREAST CANCER IN TARRANT COUNTY: Screening, Incidence, Mortality, and Stage at Diagnosis Updated January 2014 *Supported by the National Institute
More informationThe Effect of Changing Hysterectomy Prevalence on Trends in Endometrial Cancer, SEER
The Effect of Changing Hysterectomy Prevalence on Trends in Endometrial Cancer, SEER 1992-2008 Annie Noone noonea@mail.nih.gov Missy Jamison, Lynn Ries, Brenda Edwards NAACCR 2012 Portland, OR Outline
More informationOpportunities for Cancer Control An overview of screen-detectable and tobacco-related cancer in New Mexico
Opportunities for Cancer Control An overview of screen-detectable and tobacco-related cancer in New Mexico Prepared by the New Mexico Tumor Registry for the New Mexico Department of Health February 1,
More informationIncidence of Surgically Treated Benign Prostatic Hypertrophy and of Prostate Cancer among Blacks and Whites in a Prepaid Health Care Plan
American Journal of EpKtermotogy Vo! 134, No 8 Copyright C 1991 by The Johns Hopkrts Uruversfty School of Hygiene and Put*: Health Printed in US A AS rights reserved A BRIEF ORIGINAL CONTRIBUTION Incidence
More informationTrends in Lung Cancer Morbidity and Mortality
Trends in Lung Cancer Morbidity and Mortality American Lung Association Epidemiology and Statistics Unit Research and Program Services Division November 2014 Table of Contents Trends in Lung Cancer Morbidity
More informationJOURNAL OF INTERNATIONAL ACADEMIC RESEARCH FOR MULTIDISCIPLINARY Impact Factor 1.393, ISSN: , Volume 2, Issue 2, March 2014
INCIDENCE OF PRIMARY HEAD AND NECK CANCERS AT B K L W HOSPITAL & RURAL MEDICAL COLLEGE, A TERTIARY CARE CENTRE IN KONKAN, MAHARASHTRA RAJASHREE A KULKARNI* MAHESH S PATIL** *Assistant Professor, Dept.
More informationCancer survival in Bhopal, India,
Chapter 13 Cancer survival in Bhopal, India, 1991 1995 Dikshit R, Kanhere S and Surange S Abstract The Bhopal population-based cancer registry was established in 1986 under the national cancer registry
More informationCurrent HPV-Related Cancer Rates New Jersey State Cancer Registry
Current HPV-Related Cancer Rates New Jersey State Cancer Registry Antoinette M. Stroup, PhD, Director HPV NJ Roundtable October 11, 2017 American Cancer Society South Brunswick, NJ Rutgers, The State University
More informationLouisiana Cancer Facts & Figures, Urinary Bladder Cancer, 2016
Louisiana Cancer Facts & Figures, Urinary Bladder Cancer, 2016 Louisiana Tumor Registry September, 2016 Urinary Bladder Cancer* From 2009 to 2013, urinary bladder cancer was the 7 th most common cancer
More informationRisk Factors in African-American Women. Michele L. Cote, PhD Associate Professor Wayne State t University
Risk Factors in African-American Women Michele L. Cote, PhD Associate Professor Wayne State t University it Age Adjusted Incidence and Mortality Rates for all Endometrial Cancers 2000-2010 by Race/Ethnicity
More informationBLACK-WHITE DIFFERENCES IN SURVIVAL FROM LATE-STAGE PROSTATE CANCER
BLACK-WHITE DIFFERENCES IN SURVIVAL FROM LATE-STAGE PROSTATE CANCER Objective: To examine differences between African Americans (Blacks) and non-hispanic Whites in risk of death after diagnosis of laterstage
More informationAn Overview of Survival Statistics in SEER*Stat
An Overview of Survival Statistics in SEER*Stat National Cancer Institute SEER Program SEER s mission is to provide information on cancer statistics in an effort to reduce the burden of cancer among the
More informationPAPILLARY THYROID CANCER IS A
ORIGINAL ARTICLE Thyroid Cancer Survival in the United States Observational Data From 1973 to 2005 Louise Davies, MD, MS; H. Gilbert Welch, MD, MPH Objective: To compare the survival rate of people with
More informationThe incidence of salivary carcinoma ex pleomorphic adenoma: A SEER database review and review of the literature
ORIGINAL ARTICLE The incidence of salivary carcinoma ex pleomorphic adenoma: A SEER database review and review of the literature Carl Rebhun, Richard O. Wein 1. School of Medicine, Tufts University, United
More informationRare Cancer Prevalence in the SEER Population: Hepatobiliary Cancers,
Rare Cancer Prevalence in the SEER Population: Hepatobiliary Cancers, 1975-2015 NAACCR 2018 Annual Conference Andrea Ayers, MPH Outline 1. Rare cancer classification 2. Hepatobiliary cancers 3. Key analytic
More informationHypopharynx. 1. Introduction. 1.1 General Information and Aetiology
Hypopharynx 1. Introduction 1.1 General Information and Aetiology The human pharynx is the part of the throat situated between the nasal cavity and the esophagus and can be divided into three parts: the
More informationBILATERAL BREAST CANCER INCIDENCE AND SURVIVAL
BILATERAL BREAST CANCER INCIDENCE AND SURVIVAL Kieran McCaul A thesis submitted for fulfilment of the requirements for the degree of Doctor of Philosophy Discipline of Public Health Faculty of Health Sciences
More informationEstimated Minnesota Cancer Prevalence, January 1, MCSS Epidemiology Report 04:2. April 2004
MCSS Epidemiology Report 04:2 Suggested citation Perkins C, Bushhouse S.. Minnesota Cancer Surveillance System. Minneapolis, MN, http://www.health.state.mn.us/divs/hpcd/ cdee/mcss),. 1 Background Cancer
More informationCancers of the Upper Aerodigestive Tract in Ontario, Canada, and the United States
1728 Cancers of the Upper Aerodigestive Tract in Ontario, Canada, and the United States David P. Skarsgard, M.D. 1 Patti A. Groome, Ph.D. 1 William J. Mackillop, M.B. 1 Sam Zhou, M.A. 1 Deanna Rothwell,
More informationEvaluation and Management of Head and Neck Cancer in Patients with Fanconi anemia David I. Kutler, M.D., F.A.C.S.
Evaluation and Management of Head and Neck Cancer in Patients with Fanconi anemia David I. Kutler, M.D., F.A.C.S. Residency Site Director Weill Cornell Medical Center Associate Professor Division of Head
More informationLouisiana Cancer Facts & Figures, Non-Hodgkin Lymphoma, 2016
Louisiana Cancer Facts & Figures, Non-Hodgkin Lymphoma, 2016 Louisiana Tumor Registry September, 2016 Non-Hodgkin Lymphoma Non-Hodgkin lymphoma was the 6th most common cancer in Louisiana, and the 8th
More informationDuring the past 2 decades, an increase in the ageadjusted
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2006;4:104 110 Racial Differences in Survival of Hepatocellular Carcinoma in the United States: A Population-Based Study JESSICA A. DAVILA* and HASHEM B. EL SERAG*,
More informationChanging patterns of tonsillar squamous cell carcinoma in the United States
Cancer Causes and Control 11: 489±495, 2000. 489 Ó 2000 Kluwer Academic Publishers. Printed in the Netherlands. Changing patterns of tonsillar squamous cell carcinoma in the United States Morten Frisch
More informationJ Clin Oncol 26: by American Society of Clinical Oncology INTRODUCTION
VOLUME 26 NUMBER 4 FEBRUARY 1 28 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T Incidence Trends for Human Papillomavirus Related and Unrelated Oral Squamous Cell Carcinomas in the United States
More informationUpdate of the role of Human Papillomavirus in Head and Neck Cancer
Update of the role of Human Papillomavirus in Head and Neck Cancer 2013 International & 12 th National Head and Neck Tumour Conference Shanghai, 11 13 Oct 2013 Prof. Paul KS Chan Department of Microbiology
More informationCancer prevalence. Chapter 7
Chapter 7 Cancer prevalence Prevalence measures the number of people diagnosed with cancer who are still alive. This chapter presents current and historical statistics on cancer prevalence in Ontario.
More informationWorking Group: This report will be written within the Second Malignancy Working Group.
Title: Human papillomavirus (HPV)-associated malignancies as second cancers in childhood cancer survivors: a report from the Childhood Cancer Survivor Study Working Group: This report will be written within
More informationLouisiana Cancer Facts & Figures, Stomach Cancer
Louisiana Cancer Facts & Figures, Stomach Cancer Louisiana Tumor Registry January 5, 2016 Stomach Cancer* Stomach cancer was the 17 th most commonly diagnosed cancer in both the U.S. and in Louisiana.
More informationP the esophagus may differ from those of squamous
Incidence of Cancer of the Esophagus in the US by Histologic Type PAUL c. YANG, MD, MPH, AND SCOTT DAVIS, PHD' Data from nine US population-based cancer registries participating in the Surveillance, Epidemiology,
More informationLouisiana Cancer Facts & Figures, Cervical Cancer, 2016
Louisiana Cancer Facts & Figures, Cervical Cancer, 06 Louisiana Tumor Registry September, 06 Cervical Cancer * Cervical cancer was the 5 th most commonly diagnosed cancer in Louisiana, and 6 th in the
More informationSTUDY. Subsequent Cancers After In Situ and Invasive Squamous Cell Carcinoma of the Skin
Subsequent Cancers After In Situ and Invasive Squamous Cell Carcinoma of the Skin Kari Hemminki, MD, PhD; Chuanhui Dong, MD, PhD STUDY Objectives: To compare cancer risks after in situ and invasive squamous
More informationAnnual Report to the Nation on the Status of Cancer, , with a Special Feature Regarding Survival
University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Public Health Resources Public Health Resources 7-1-2004 Annual Report to the Nation on the Status of Cancer, 1975 2001,
More information2. Studies of Cancer in Humans
452 IARC MONOGRAPHS VOLUME 98 2. Studies of Cancer in Humans 2.1 Cohort studies (Tables 2.1 and 2.2) Among municipal, five studies evaluated the incidence of cancer and 15 assessed mortality some with
More informationHazelinks - Cancer incidence analysis (First data extraction)
Hazelinks - Cancer incidence analysis (First data extraction) Authors Prof Malcolm Sim Ms Christina Dimitriadis Dr Caroline Gao Mr Anthony Del Monaco 1 1 Contents Abbreviations... 3 Executive Summary...
More informationAnnual Report to the Nation on the Status of Cancer, , Featuring the Increasing Incidence of Liver Cancer
Annual Report to the Nation on the Status of Cancer, 1975-, Featuring the Increasing Incidence of Liver Cancer A. Blythe Ryerson, PhD, MPH 1 ; Christie R. Eheman, PhD, MSHP 1 ; Sean F. Altekruse, DVM,
More informationThe American Cancer Society estimates that there will be
ORIGINAL ARTICLE Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer Analysis of the SEER-Medicare Database Laura C. Caprario, MD, MS,* David M. Kent, MD, MS, and Gary M.
More informationARTICLE. Differences in Non-Hodgkin Lymphoma Survival Between Young Adults and Children
ARTICLE Differences in Non-Hodgkin Lymphoma Survival Between Young Adults and Children Eric Tai, MD; Lori A. Pollack, MD; Julie Townsend, MS; Jun Li, MD; C. Brooke Steele, DO; Lisa C. Richardson, MD Objective:
More informationCancer survival and prevalence in Tasmania
Cancer survival and prevalence in Tasmania 1978-2008 Cancer survival and prevalence in Tasmania 1978-2008 Tasmanian Cancer Registry University of Tasmania Menzies Research Institute Tasmania 17 Liverpool
More informationNested case-control study of leukaemia, multiple myeloma, and kidney cancer in a cohort of petroleum workers exposed to gasoline
Occup Environ Med 1999;56:217 221 217 Applied Health Sciences, San Mateo, California, USA O Wong L Trent F Harris Tulane University Medical Center, New Orleans, Louisiana, USA O Wong University of California,
More informationLouisiana Cancer Facts & Figures, Kidney and Renal Pelvis Cancer, 2016
Louisiana Cancer Facts & Figures, Kidney and Renal Pelvis Cancer, 2016 Louisiana Tumor Registry December 5, 2016 Kidney and Renal Pelvis Cancer From 2009 to 2013, Louisiana had the highest incidence rate
More informationCHILDHOOD CANCER SURVIVOR STUDY ANALYSIS CONCEPT PROPOSAL
CHILDHOOD CANCER SURVIVOR STUDY ANALYSIS CONCEPT PROPOSAL 1. Study title: Subsequent neoplasms among survivors of childhood cancer not previously treated with radiation 2. Working group and investigators:
More informationOVER the past three decades, numerous randomized
Journal of Gerontology: MEDICAL SCIENCES 2005, Vol. 60A, No. 9, 1137 1144 Copyright 2005 by The Gerontological Society of America Effectiveness of Adjuvant for Node-Positive Operable Breast Cancer in Older
More informationLouisiana Cancer Facts & Figures, Pancreatic Cancer, 2016
Louisiana Cancer Facts & Figures, Pancreatic Cancer, 2016 Louisiana Tumor Registry September, 2016 Pancreatic Cancer * Pancreatic cancer was the 10 th most commonly diagnosed cancer in Louisiana, and 12
More informationCancer Facts & Figures for African Americans
Cancer Facts & Figures for African Americans What is the Impact of Cancer on African Americans in Indiana? Table 12. Burden of Cancer among African Americans Indiana, 2004 2008 Average number of cases
More informationKey words: Nasopharynx, oropharyngeal, squamous, carcinomas, epidemiology, snuffed tobacco.
-(study of 314 cases) Abuidris DO, Elhaj AHA, Eltayeb EA, Elgayli EM and El Mustafa OM ABSTRACT Objective: The objective of this work is to study the patterns of head and neck malignancies (HNM) in central
More informationApplication of EM Algorithm to Mixture Cure Model for Grouped Relative Survival Data
Journal of Data Science 5(2007), 41-51 Application of EM Algorithm to Mixture Cure Model for Grouped Relative Survival Data Binbing Yu 1 and Ram C. Tiwari 2 1 Information Management Services, Inc. and
More informationSecond cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study
British Journal of Cancer (2011) 105, 1076 1081 All rights reserved 0007 0920/11 www.bjcancer.com Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based
More informationOverview of 2010 Hong Kong Cancer Statistics
Overview of 2010 Hong Kong Cancer Statistics Cancer Registration in Hong Kong The Hong Kong Cancer Registry has since the 1960s been providing population-based cancer data for epidemiological research
More informationHealth Consultation CHILDHOOD CANCER INCIDENCE UPDATE: A REVIEW AND ANALYSIS OF CANCER REGISTRY DATA, FOR
Health Consultation CHILDHOOD CANCER INCIDENCE UPDATE: A REVIEW AND ANALYSIS OF CANCER REGISTRY DATA, 2001-2005 FOR TOWNSHIP OF TOMS RIVER, OCEAN COUNTY, NEW JERSEY AUGUST 20, 2008 U.S. DEPARTMENT OF HEALTH
More informationAnnual Report to the Nation on the Status of Cancer, , Featuring Survival
JNCI J Natl Cancer Inst (217) 19(9): djx3 doi: 1.193/jnci/djx3 First published online March 31, 217 Article Annual Report to the Nation on the Status of Cancer, 1975 214, Featuring Survival Ahmedin Jemal,
More informationBiological Cure. Margaret R. Stedman, Ph.D. MPH Angela B. Mariotto, Ph.D.
Using Cure Models to Estimate Biological Cure Margaret R. Stedman, Ph.D. MPH Angela B. Mariotto, Ph.D. Data Modeling Branch Surveillance Research Program Division of Cancer Control and Population Sciences
More informationAlthough thymic tumors are the most common tumors of
ORIGINAL ARTICLE The Role of Radiation Therapy in Malignant Thymoma A Surveillance, Epidemiology, and End Results Database Analysis Annemarie T. Fernandes, BA,* Eric T. Shinohara, MD,* Mengye Guo, PhD,
More informationParanasal Sinus Squamous Cell Carcinoma Incidence and Survival Based on Surveillance, Epidemiology, and End Results Data, 1973 to 2009
Paranasal Sinus Squamous Cell Carcinoma Incidence and Survival Based on Surveillance, Epidemiology, and End Results Data, 1973 to 2009 Benjamin Ansa, MD, MSCR 1 ; Michael Goodman, MD, MPH 2 ; Kevin Ward,
More informationBackground. Background. AYA Overview. Epidemiology of AYA Cancers in Texas
Texas Cancer Registry: Who We Are Epidemiology of AYA Cancers in Texas Melanie Williams, Ph.D. Texas Cancer Registry Cancer Epidemiology and Surveillance Branch Texas Department of State Health Services
More informationSynchronous Cancers in Patients With Head and Neck Cancer
Original Article Synchronous Cancers in With Head and Neck Cancer Risks in the Era of Human Papillomavirus-Associated Oropharyngeal Cancer Kunal S. Jain, MD 1,2 ; Andrew G. Sikora, MD, PhD 3 ; Shrujal
More informationEndoscopic ultrasound and impact on survival in rectal cancer patients : a SEER-Medicare study.
Oregon Health & Science University OHSU Digital Commons Scholar Archive October 2010 Endoscopic ultrasound and impact on survival in rectal cancer patients : a SEER-Medicare study. Steven McNamara Follow
More informationINCIDENCE AND SURVIVAL IN PATIENTS WITH SINONASAL CANCER: A HISTORICAL ANALYSIS OF POPULATION-BASED DATA
ORIGINAL ARTICLE INCIDENCE AND SURVIVAL IN PATIENTS WITH SINONASAL CANCER: A HISTORICAL ANALYSIS OF POPULATION-BASED DATA Justin H. Turner, MD, PhD, Douglas D. Reh, MD Department of Otolaryngology Head
More informationReport prepared on behalf of the Scottish Head and Neck Cancer Networks by the WoSCAN Information Team
Scottish Head and Neck Cancer Networks Report of the 2011 Clinical Audit Data Presented at the National Head and Neck Cancer Education Day 26th October 2012 Report prepared on behalf of the Scottish Head
More informationOverview of Hong Kong Cancer Statistics of 2015
Overview of Hong Kong Cancer Statistics of 2015 This report summarizes the key cancer statistics of Hong Kong for the year of 2015, which is now available on the website of Hong Kong Cancer Registry. Cancer
More informationCancer survival in Busan, Republic of Korea,
Cancer survival in Busan, Republic of Korea, 1996 2001 Shin HR, Lee DH, Lee SY, Lee JT, Park HK, Rha SH, Whang IK, Jung KW, Won YJ and Kong HJ Abstract The Busan cancer registry was established in 1996;
More informationCancer Statistics, 2011
Cancer Statistics, 2011 Cancer Statistics, 2011 The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths Rebecca Siegel, MPH 1 ; Elizabeth Ward, PhD 2 ; Otis Brawley, MD
More informationAdjuvant Therapy in Locally Advanced Head and Neck Cancer. Ezra EW Cohen University of Chicago. Financial Support
Adjuvant Therapy in Locally Advanced Head and Neck Cancer Ezra EW Cohen University of Chicago Financial Support This program is made possible by an educational grant from Eli Lilly Oncology, who had no
More informationPREVIEW OF REGISTRY-SPECIFIC AND AGGREGATED RELATIVE SURVIVAL ESTIMATES IN CANCER IN NORTH AMERICA
PREVIEW OF REGISTRY-SPECIFIC AND AGGREGATED RELATIVE SURVIVAL ESTIMATES IN CANCER IN NORTH AMERICA CINA SURVIVAL Authors: Chris Johnson, Deborah Hurley, Angela Mariotto, Reda Wilson, Donna Turner, Hannah
More informationRisk of Second Primary Malignancies Among Cancer Survivors in the United States, 1992 Through 2008
Risk of Second Primary Malignancies Among Cancer Survivors in the United States, 1992 Through 2008 Nicholas Donin, MD 1 ; Christopher Filson, MD, MS 2,3 ; Alexandra Drakaki, MD, PhD 1,4,5 ; Hung-Jui Tan,
More informationMalignant Fibrous Histiocytoma: Database Review Suggests a Favorable Prognosis in the Head and Neck
The Laryngoscope VC 2017 The American Laryngological, Rhinological and Otological Society, Inc. Malignant Fibrous Histiocytoma: Database Review Suggests a Favorable Prognosis in the Head and Neck Robert
More informationANNUAL CANCER REGISTRY REPORT-2005
ANNUAL CANCER REGISTRY REPORT-25 CANCER STATISTICS Distribution of neoplasms Of a total of 3,115 new neoplasms diagnosed or treated at the Hospital from January 25 to December, 25, 1,473 were seen in males
More informationCUTANEOUS MALIGNANT MELANOMA AMONG WHITE HISPANICS AND NON-HISPANICS
CUTANEOUS MALIGNANT MELANOMA AMONG WHITE HISPANICS AND NON-HISPANICS IN THE UNITED STATES Aim: To explore whether disparities exist in melanoma incidence and prognosis between White Hispanics and White
More informationHead and Neck Squamous Subtypes
1 Head and Neck Squamous Subtypes Adel K. El-Naggar, M.D., Ph.D. The University of Texas MD Anderson Cancer Center, Houston, Texas HNSCC 5 th -6 th most common cancer 400,000/year 50% mortality Considerable
More informationLong-term survival rate of stage I-III small cell lung cancer patients in the SEER database - application of the lognormal model
Long-term survival rate of stage I-III small cell lung cancer patients in the SEER database - application of the lognormal model Patricia Tai, MD, (Acting Director of Radiation Oncology), Edward Yu, MD,
More information